Interleukin enhancer‑binding factor 3 (ILF3) may function as a transcriptional coactivator and
has been reported to be involved in tumor proliferation and metastasis; however, its role and …

The aim of this study is to investigate the expression levels and clinical significance of ILF2
in gastric cancer. The mRNA and protein expression levels of ILF2 were, respectively …

Purpose The interferon regulatory factor 2 (IRF-2) acted as a tumor suppressor. We
inspected IRF-2 as a predictor of prognosis in gastric cancer (GC) patients and tried to find …

Background Interferon regulatory factor 2 (IRF-2) acts as an anti-oncogene in gastric cancer
(GC); however, the underlying mechanism remains unknown. Methods This study …

Interferon regulatory factor 6 (IRF6) acts as a tumor suppressor and controls cell
differentiation in ectodermal and craniofacial tissues by regulating expression of target …

Background/Aims: The status of interferon (IFN) signaling pathway has been shown to be
closely associated with the response of immune checkpoint blockade therapy against …

Background: Interleukin-1 receptor type II (IL-1R2), also known as CD121b, is a member of
the IL-1 receptor family. IL-1R2 acts as negative regulator of the IL-1 system, modulating IL-1 …

Interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a transcriptional repressor
involved in regulating gene expression and other biological processes, including …

Background Stomach adenocarcinoma (STAD) is one of the most prevalent malignances,
ranking fifth in incidence and third in mortality among all malignances. Interferon regulatory …

Interleukin enhancer binding factor 2 (ILF2), a transcription factor, regulates cell growth by
inhibiting the stabilization of mRNA. Currently, its role has gained recognition as a factor in …